Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	879.52	526.42	339.15	438.68	135.99
Cash & Short-Term Investments	879.52	526.42	339.15	438.68	135.99
Cash Growth	67.07%	55.22%	-22.69%	222.58%	47.63%
Accounts Receivable	-	-	2.05	1	5.46
Other Receivables	35.65	24.04	19.16	10.91	9.18
Receivables	35.65	24.04	21.21	11.91	14.63
Prepaid Expenses	13.43	11.41	9.02	7.97	5.1
Total Current Assets	928.61	561.87	369.38	458.56	155.72
Property, Plant & Equipment	17.19	27.68	32.77	17.79	3.61
Other Long-Term Assets	11.07	5.79	8.46	3.45	1.82
Total Assets	956.87	595.34	410.61	479.79	161.15
Accounts Payable	15.79	13.05	6.47	2.72	1.37
Accrued Expenses	35.45	26.38	21.86	11.29	10.58
Current Portion of Leases	5.5	4.88	3.13	2.38	0.84
Current Unearned Revenue	10.19	24.98	20.42	19.27	10.14
Other Current Liabilities	0.3	0.26	1.47	0.57	0.21
Total Current Liabilities	67.23	69.54	53.34	36.24	23.13
Long-Term Debt	-	30.7	30.32	29.87	14.51
Long-Term Leases	3.99	9.38	10.89	12.08	0.43
Long-Term Unearned Revenue	91.47	110.22	41.46	52.07	25.02
Other Long-Term Liabilities	1.12	4.58	3.83	3.28	2.61
Total Liabilities	163.81	224.41	139.83	133.54	65.69
Common Stock	0.89	0.55	0.39	0.38	0.27
Additional Paid-In Capital	1,473	883.45	601.11	567.64	249.95
Retained Earnings	-680.79	-511.76	-331.1	-218.38	-151.56
Comprehensive Income & Other	0.12	-1.3	0.39	-3.39	-3.19
Total Common Equity	793.06	370.93	270.78	346.25	95.46
Shareholders' Equity	793.06	370.93	270.78	346.25	95.46
Total Liabilities & Equity	956.87	595.34	410.61	479.79	161.15
Total Debt	9.49	44.96	44.33	44.34	15.78
Net Cash (Debt)	870.03	481.47	294.83	394.34	120.22
Net Cash Growth	80.70%	63.30%	-25.24%	228.03%	33.24%
Net Cash Per Share	14.95	13.53	9.94	15.73	6.28
Filing Date Shares Outstanding	69.2	42.59	30.02	29.6	23.09
Total Common Shares Outstanding	69.06	42.43	29.87	29.58	21.09
Working Capital	861.38	492.33	316.04	422.32	132.59
Book Value Per Share	11.48	8.74	9.06	11.71	4.53
Tangible Book Value	793.06	370.93	270.78	346.25	95.46
Tangible Book Value Per Share	11.48	8.74	9.06	11.71	4.53
Machinery	16.53	16.91	16.24	7.11	5.97
Leasehold Improvements	10.9	11	10.74	0.81	0.38

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q